An efficient approach for the enzyme-enhanced extraction of camptothecin and 10-Hydroxycamptothecin (cas 19685-09-7) from the samara of Camptotheca acuminata using an ionic liquid solution
-
Add time:09/06/2019 Source:sciencedirect.com
An efficient approach for enzyme-enhanced extraction using an ionic liquid solution (ILEEE) of the major alkaloidal components camptothecin (CPT) and 10-Hydroxycamptothecin (cas 19685-09-7) (HCPT) from the samara of Camptotheca acuminata is presented. The enzyme pretreatment in an aqueous ionic liquid (IL) media was used for the enhancement of extraction yield. The activity of hemicellulase was investigated in various ILs with imidazolium-based cations ([C2MIM]+, [C4MIM]+, [C6MIM]+, [C8MIM]+, [C10MIM]+) and anions (Br−, Cl−, Ac−, HSO4−, NO3−). The optimal ionic liquid for the hemicellulase extraction process was found to be a 0.75 M [C8MIM]Br aqueous solution. Single factor experiments and Box–Behnken design found the optimal operational parameters for ILEEE to be an incubation temperature of 40 °C, incubation time of 12 h, extraction phase of pH 4, liquid-solid ratio of 30 mL/g, 0.75 M [C8MIM]Br and a hemicellulase concentration of 0.441 mg/mL. Under these optimized extraction conditions, the total yield of CPT and HCPT was 1043 ± 51.2 μg/g. SEM images of the samples revealed that hemicellulases hydrolyze the cell wall, leading to structure breakdown, which enabled [C8MIM]Br to have a high dissolving power for the targeted components. These factors are the main causes for the increasing in the total yield of the CPT and HCPT when using the ILEEE extraction method.
We also recommend Trading Suppliers and Manufacturers of 10-Hydroxycamptothecin (cas 19685-09-7). Pls Click Website Link as below: cas 19685-09-7 suppliers
Prev:Review articleAntibody-drug conjugates of 7-ethyl-10-Hydroxycamptothecin (cas 19685-09-7): Sacituzumab govitecan and labetuzumab govitecan
Next:Full Length ArticleIn vitro and in vivo evaluation of 10-Hydroxycamptothecin (cas 19685-09-7)-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original articleStudy the voltammetric behavior of 10-Hydroxycamptothecin (cas 19685-09-7) and its sensitive determination at electrochemically reduced graphene oxide modified glassy carbon electrode09/08/2019
- Full Length ArticleIn vitro and in vivo evaluation of 10-Hydroxycamptothecin (cas 19685-09-7)-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization09/07/2019
- Review articleAntibody-drug conjugates of 7-ethyl-10-Hydroxycamptothecin (cas 19685-09-7): Sacituzumab govitecan and labetuzumab govitecan09/05/2019
- Incorporation of 10-Hydroxycamptothecin (cas 19685-09-7) nanocrystals into zein microspheres09/04/2019
- Monodisperse oligoethylene glycols modified Camptothecin, 10-Hydroxycamptothecin (cas 19685-09-7) and SN38 prodrugs09/03/2019
- ORIGINAL ARTICLEMenthol-modified casein nanoparticles loading 10-Hydroxycamptothecin (cas 19685-09-7) for glioma targeting therapy09/02/2019
- Full Length ArticleSelf-assembly behavior of amphiphilic poly(ethylene glycol)-conjugated 10-Hydroxycamptothecin (cas 19685-09-7) in water and its cytotoxicity assay09/01/2019
- Enzyme/pH dual-responsive polymer prodrug nanoparticles based on 10-Hydroxycamptothecin (cas 19685-09-7)-carboxymethylchitosan for enhanced drug stability and anticancer efficacy08/31/2019
-
Health and Chemical more >
-
Related Products


